Stock exchange and press releases of BBS will be published on these pages. Releases are published in Finnish and in English.
Contact information for the media: info@bbs-artebone.fi from which you can also request additional media material.
25.10.2023
CORRECTION: Resolutions of the Extraordinary General Meeting of BBS-Bioactive Bone Substitutes Plc
23.10.2023
Resolutions of the Extraordinary General Meeting of BBS-Bioactive Bone Substitutes Plc
28.09.2023
Correction: Notice to the BBS-Bioactive Bone Substitutes Plc’s Extraordinary General Meeting
28.09.2023
Notice to the BBS-Bioactive Bone Substitutes Plc’s Extraordinary General Meeting
25.08.2023
BBS-Bioactive Bone Substitutes Plc: Half-Year Financial Report 1 Jan - 30 Jun 2023 (unaudited)
07.08.2023
BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Ahti Paananen
07.08.2023
BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Jarmo Halonen
07.08.2023
BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Pekka Jalovaara
30.03.2023
BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2023
14.12.2022
BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2023
31.08.2022
BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Pekka Jalovaara
31.08.2022
BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Ahti Paananen
31.08.2022
BBS-Bioactive Bone Substitutes Plc: Change in BBS-Bioactive Bonesubstitutes Plc’s management
25.08.2022
BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Oili Halonen
25.08.2022
BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Pekka Jalovaara
25.08.2022
BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Jarmo Halonen
25.08.2022
BBS-Bioactive Bone Substitutes Plc: Half-Year Financial Report, 1 January – 30 June 2022 (unaudited)
08.08.2022
Changes in the BBS-Bioactive Bone Substitutes Plc’s Management Team
08.06.2022
BBS-Bioactive Bone Substitutes Plc’s rights issue raised gross proceeds of EUR 3.5 million
09.05.2022
BBS publishes EU growth prospectus in connection to its EUR 4.5 million rights issue
29.04.2022
BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2022
05.04.2022
Invitation to the Bbs-Bioactive Bone Substitutes Plc’s Annual General Meeting (AGM)
29.03.2022
BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2021 has been published
17.03.2022
BBS-Bioactive Bone Substitutes Plc: Decisions of the Extraordinary General Meeting 2022
24.02.2022
Invitation to the Extraordinary General Meeting of Bbs-Bioactive Bone Substitutes Plc
24.02.2022
BBS-Bioactive Bone Substitutes Plc: Financial Statements Review 1.1.-31.12.2021 (unaudited)
11.01.2022
BBS-Bioactive Bone Substitutes Plc: US Patent for the Manufacture of ARTEBONE® product
10.12.2021
BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2022
25.08.2021
BBS-Bioactive Bone Substitutes Plc: Half-Year Report January 1st –June 30th 2021 (Unaudited)
29.04.2021
BBS-Bioactive Bone Substitutes Plc - CORRECTION: Decisions of the Annual General Meeting 2021
28.04.2021
BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2021
08.04.2021
BBS-Bioactive Bone Substitutes Plc: CORRECTION TO THE INVITATION TO THE ANNUAL GENERAL MEETING
31.03.2021
BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2020 has been published
24.02.2021
BBS-Bioactive Bone Substitutes Plc: Financial Statements Review 1.1.-31.12.2020 (unaudited)
01.02.2021
BBS-Bioactive Bone Substitutes Plc: CFO will change on 1 February, 2021
26.06.2020
BBS-Bioactive Bone Substitutes Plc: Directed share issue to shareholder
25.06.2020
BBS-Bioactive Bone Substitutes Plc: Managers' Transactions
12.06.2020
BBS-Bioactive Bone Substitutes Plc: Today is the last day of trading in subscription rights
09.04.2020
BBS-Bioactive Bone Substitutes Plc: Financial Statements for 2019 have been published
20.03.2020
BBS-Bioactive Bone Substitutes Plc: Financial Statements Review 1.1.-31.12.2019 (unaudited)
25.11.2023
BBS-Bioactive Bone Substitutes: The Notified Body has approved the Company’s quality system
Older releases can be found from our news archive.